This article has been updated to clarify the consumer-facing genetic testing models of Invitae and Color.
NEW YORK (GenomeWeb) – Patient advocates, researchers, and leading testing labs are disappointed with the US Preventive Services Task Force's draft recommendations on genetic testing for BRCA-related cancers for not reflecting the growing body of evidence that shows that a family history-focused screening strategy misses a significant swathe of the at-risk population.